The U.S. Food and Drug Administration has approved the combination of cefepime and enmetazobactam (FPE) for the treatment of complicated urinary tract infections (cUTIs).
PHARMACOLOGY UPDATE
Cefepime and Enmetazobactam Injection (Exblifep)
July 1, 2024